Paper35533474
Lung transplantation in the COVID-19 Era: A multi-faceted challenge.
Messika J and 4 others. Respir Med Res, 2022. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Lung transplantation in the COVID-19 Era: A multi-faceted challenge. Papers, record 35533474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35533474
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Lung Transplantation | Major topic |
| Humans |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32278082 | Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre. | Clin Microbiol Infect | 2020 | https://conductscience.org/library/papers/32278082 | PubMed |
| 2 | 32659028 | Organ donation during the COVID-19 pandemic. | Am J Transplant | 2020 | https://conductscience.org/library/papers/32659028 | PubMed |
| 3 | 32301803 | Lung Transplantation for Elderly Patients With End-Stage COVID-19 Pneumonia. | Ann Surg | 2020 | https://conductscience.org/library/papers/32301803 | PubMed |
| 4 | 32563968 | Proposals for managing patients with thoracic malignancies during COVID-19 pandemic. | Respir Med Res | 2020 | https://conductscience.org/library/papers/32563968 | PubMed |
| 5 | 34579953 | Lung Transplantation for End-Stage Respiratory Failure After Severe COVID-19: A Report of 2 Cases. | Transplant Proc | 2021 | https://conductscience.org/library/papers/34579953 | PubMed |
| 6 | 32505492 | Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement. | J Heart Lung Transplant | 2020 | https://conductscience.org/library/papers/32505492 | PubMed |
| 7 | 33098200 | COVID-19 in transplant recipients: The Spanish experience. | Am J Transplant | 2021 | https://conductscience.org/library/papers/33098200 | PubMed |
| 8 | 33606480 | Lung Transplantation for Severe Post-coronavirus Disease 2019 Respiratory Failure. | Transplantation | 2021 | https://conductscience.org/library/papers/33606480 | PubMed |
| 9 | 34224673 | Lung transplantation for COVID-19-associated ARDS. | Lancet Respir Med | 2021 | https://conductscience.org/library/papers/34224673 | PubMed |
| 10 | 34474014 | COVID-19 pandemic and worldwide organ transplantation: a population-based study. | Lancet Public Health | 2021 | https://conductscience.org/library/papers/34474014 | PubMed |
| 11 | 33141808 | COVID-19 in Lung Transplant Recipients. | Transplantation | 2021 | https://conductscience.org/library/papers/33141808 | PubMed |
| 12 | 32474398 | Impact of the Covid-19 pandemic and lung transplantation program in France. | Respir Med Res | 2020 | https://conductscience.org/library/papers/32474398 | PubMed |
| 13 | 34580142 | Lung transplantation for acute COVID-19: the Toronto Lung Transplant Program experience. | CMAJ | 2021 | https://conductscience.org/library/papers/34580142 | PubMed |
| 14 | 32857989 | When to consider lung transplantation for COVID-19. | Lancet Respir Med | 2020 | https://conductscience.org/library/papers/32857989 | PubMed |
| 15 | 32243281 | Global Transplantation COVID Report March 2020. | Transplantation | 2020 | https://conductscience.org/library/papers/32243281 | PubMed |
| 16 | 32563967 | Covid-19: Adapting the geriatric organisations to respond to the pandemic. | Respir Med Res | 2020 | https://conductscience.org/library/papers/32563967 | PubMed |
| 17 | 33811829 | Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. | Lancet Respir Med | 2021 | https://conductscience.org/library/papers/33811829 | PubMed |
| 18 | 34433119 | Lung transplantation for COVID-19-associated acute respiratory distress syndrome: The first French patient. | Respir Med Res | 2021 | https://conductscience.org/library/papers/34433119 | PubMed |
| 19 | 33368697 | The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first wave. | Clin Transplant | 2021 | https://conductscience.org/library/papers/33368697 | PubMed |
| 20 | 32243677 | The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs. | Am J Transplant | 2020 | https://conductscience.org/library/papers/32243677 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37721597 | [When mechanical ventilation fails-Venovenous extracorporeal membrane oxygenation]. | Inn Med (Heidelb) | 2023 | https://conductscience.org/library/papers/37721597 | PubMed |
| 36630777 | The pandemic effect: The outlook of lung transplantation. | Respir Med Res | 2023 | https://conductscience.org/library/papers/36630777 | PubMed |
| 36152040 | CT imaging findings in lung transplant recipients with COVID-19. | Eur Radiol | 2023 | https://conductscience.org/library/papers/36152040 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35533474
GET https://conductscience.org/api/papers/v1/35533474/references?page=2